CUTR News and Press, Cutera Inc. From 01/30/23

Summary AirSculpt Technologies has potential to be a niche operator in a crowded space of human plastics. Since listing, shares have crumbled, as investors re-rated the stock heavily to the downside. However, the re-rating looks more than justified, and we demonstrate that future gr...

Cantor Fitzgerald downgraded Cutera, Inc. ( NASDAQ: CUTR ) to Neutral from Overweight on Tuesday after the medical device company pre-announced its 2022 financials indicating $252M – $253M revenue for the last year. The estimate, based on preliminary, unaudited financials, impl...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022. These results are subject to the completion o...

Summary INMD provides a prime opportunity for investors to benefit from the growing demand for non-surgical cosmetic procedures that rely on energy-based devices. INMD manufactures and sells energy based devices used by physicians in these procedures and has between 2019 and 2022 seen a...

Cutera ( NASDAQ: CUTR ) has priced a private offering of $100M aggregate principal amount of 4.00% convertible senior notes due 2029. Initial purchasers of the notes will be granted an option to purchase up to an additional $20M aggregate principal amount of the notes. The not...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced the pricing of $100 million aggregate principal amount of 4.00% convertible senior notes due 2029 (the “notes”) in a p...

Cutera ( NASDAQ: CUTR ) on Wednesday announced that it intends to offer $100 million, in convertible senior notes due 2029, in a private placement. Cutera also intends to grant the initial purchasers of the notes an option to purchase up to an additional $20 million of the notes. ...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it intends to offer, subject to market conditions and other factors, $100 million aggregate principal amount of convertible sen...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today disclosed that it has provided a response to a recent FDA inquiry. In 2019, Cutera undertook remediation to remove all marketing materials...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fires...